AbCellera Biologics Inc.
Support and Resistance Levels
Past performance
News About ABCL
All events for ABCL
All deals for ABCL
Financial Ratios
Financial Statements
ABCL vs Sector & Peers
About AbCellera Biologics Inc.
AbCellera Biologics Inc. specializes in pioneering an advanced platform for the discovery of antibodies. This comprehensive, AI-driven system meticulously explores and analyzes natural immune systems to identify antibodies suitable for the creation of new pharmaceutical drugs. As of December 31, 2021, the company had cultivated 156 discovery programs, ranging from completed to in-progress or under contract, in partnership with 36 entities. Notably, AbCellera maintains a crucial research collaboration and license agreement with Eli Lilly and Company. Founded in 2012, the firm is headquartered in Vancouver, Canada. Website abcellera.com
Headquarters Vancouver, BC, CA